NP Life Sciences Health Industry Group Inc.
ACAT· OTC
Filed Aug 14, 2020 · 10-Q · 45 days after period end · 0001493152-20-015609
| Metric | Q2 2020 | Q2 2019 |
|---|---|---|
| Revenue | $0.00 | $23.00K |
| Net Income | -$53.65K | -$4.95K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 14, 2020 · 45 d after period end